Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: A retrospective cohort study

Respiratory Research

Volumn 6, Issue , 2005, Pages

  Polosa, Riccardo ^a   Al Delaimy, Wael K ^b   Russo, Cristina ^a   Piccillo, Giovita ^a   Sarvà, Maria ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allergic rhinitis; Asthma; Cohort study; Immunotherapy; Risk factors

Indexed keywords

ALLERGEN; GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN;

ADULT; ALLERGIC RHINITIS; ANAMNESIS; ARTICLE; ASTHMA; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; DERMATOPHAGOIDES; DISEASE ASSOCIATION; DOMESTIC ANIMAL; DRUG DOSE REGIMEN; FAMILY HISTORY; FEMALE; FOLLOW UP; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ORCHARD; PASSIVE SMOKING; PERENNIAL RYEGRASS; PREDICTION; PRICK TEST; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIZATION; SEX DIFFERENCE; ADOLESCENT; COMORBIDITY; DESENSITIZATION; ITALY; PROCEDURES; RHINITIS, ALLERGIC, SEASONAL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ASTHMA; COHORT STUDIES; COMORBIDITY; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, SEASONAL; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 29644440599     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-6-153     Document Type: Article

References (45)

1. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998 Apr 25; 351(9111): 1225-32.
2. Janson C, Anto J, Burney P, Chinn S, de Marco R, Heinrich J, et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 2001; 18(3): 598-611.
3. Tattersfield AE, Knox AJ, Britton JR, Hall IP. Asthma. Lancet 2002 Oct 26; 360(9342): 1313-22.
4. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001 Nov; 108(5 Suppl): S147-334.
5. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol. 2003 Jun; 111(6): 1171-83.
6. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Asymptomatic bronchial hyperresponsiveness in rhinitis. J Allergy Clin Immunol 1985; 75: 573-577.
7. Crimi N, Palermo F, Oliveri R, Vancheri C, Di Stefano SM, Palermo B, Polosa R, Mistretta A. Influence of asthmatic and rhinitic symptomatology and duration on bronchial responsiveness to histamine. Int J Tiss React 1987; IX (6): 515-20.
8. Bradley BL, Azzawi M, Jacobson M, et al.Eosinophils, T-lymphocytes, mast cells, neutrophils and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparisons with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991; 88: 661-74.
9. Djukanovic R, Lai CKW, Wilson JW, et al. Bronchial mucosal manifestation of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic non-asthmatics and healthy controls. Eur Respir J 1992; 5: 538-44.
10. Polosa R, Ciamarra I, Mangano G, Prosperini G, Pistorio MP, Vancheri C, Crimi N. Bronchial hyperresponsiveness and airway inflammation markers in non asthmatics with allergic rhinitis. Eur Respir J 2000; 15: 30-35.
11. Braman SS, Barrows AA, DeCotiis BA, Settipane GA, Corrao WM. Airway hyperresponsiveness in allergic rhinitis: a risk factor for asthma. Chest 1987; 91: 671-74.
12. Sparrow D, O'Connor G, Colton T, Barry CL, Weiss ST. The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function: the Normative Aging Study. Am Rev Respir Dis 1987;135:1255-1260.
13. Hopp RJ, Townley RG, Biven RE, Bewtra AK, Nair NM. The presence of airway reactivity before the development of asthma. Am Rev Respir Dis 1990; 141: 2-8.
14. Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc. 1994 Jan-Feb;15(1):21-5.
15. Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol. 2002 Mar; 109(3): 419-25.
16. Leynaert B, Neukirch C, Kony S, Guenegou A, Bousquet J, Aubier M, Neukirch F. Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol. 2004 Jan; 113(1): 86-93.
17. Huovinen E, Kaprio J, Laitinen LA, Koskenvuo M. Incidence and prevalence of asthma among adult Finnish men and women of the Finnish Twin Cohort from 1975 to 1990, and their relation to hay fever and chronic bronchitis. Chest 1999;115:928-36.
18. Plaschke PP, Janson C, Norrman E, Bjornsson E, Ellbjar S, Jarvholm B. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med. 2000; 162(3 Pt 1): 920-4.
19. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102(4 Pt 1): 531-42.
20. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, Till SJ, Hamid QA, Nouri-Aria KT. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med.1999 Aug 12;341(7):468-75.
21. Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L, Koivikko A, Koller DY, Niggemann B, Norberg LA, Urbanek R, Valovirta E, Wahn U. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol. 2002 Feb;109(2):215-6.
22. Polosa R. Can immunotherapy prevent progression to asthma in allergic individuals? J Allergy Clin Immunol.2002 Oct;110(4):672-3.
23. Polosa R, Li Gotti F, Mangano G, Paolino G, Mastruzzo C, Vancheri C, Lisitano N, Crimi N. Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis. Allergy. 2004 Nov;59(11):1224-8.
24. Dykewicz MS, Fineman S, Skoner DP, Nicklas R, Lee R, Blessing-Moore J, Li JT, Bernstein IL, Berger W, Spector S, Schuller D. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol. 1998 Nov; 81(5 Pt 2): 478-518.
25. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987; 136(1): 225-44.
26. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol. 1991 Sep;88(3 Pt 2):425-534.
27. Polosa R, Phillips GD, Rajakulasingam K, Holgate ST. The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5′-monophosphate and histamine in asthma. J Allergy Clin Immunol 1991; 87(5): 939-47.
28. Stewart AW, Asher MI, Clayton TO, Crane J, D'Souza W, Ellwood PE, Ford RP, Mitchell EA, Pattemore PK, Pearce N. The effect of season-of-response to ISAAC questions about asthma, rhinitis and eczema in children. Int J Epidemiol 1997; 26(1): 126-36.
29. http://www.ginasthma.com/Guidelineitem.asp??11=2&12=1&intId=60
30. Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104:301-4.
31. Yunginger JW, Reed CE, O'Connell EJ, et al. A community based study of the epidemiology of asthma: incidence rates, 1964-1983. Am Rev Respir Dis 1992; 146: 888-94.
32. Skobeloff EM, Spivey WH, St Clair SS, et al. The influence of age and sex on asthma admissions. JAMA 1992; 268: 3437-40.
33. Burke W, Fesinmeyer M, Reed K, Hampson L, Carlsten C. Family history as a predictor of asthma risk. Am J Prev Med 2003; 24: 160-9.
34. Ahlbom A, Backman A, Bakke J, Foucard T, Halken S, Kjellman NIM, et al. NORDPET: Pets indoors - A risk factor for or protection against sensitization/allergy. Indoor Air 1998;8:219-35.
35. Apelberg BJ, Aoki Y, Jaakkola JJ. Systematic review: Exposure to pets and risk of asthma and asthmalike symptoms. J Allergy Clin Immunol 2001; 107(3): 455-60.
36. Platts-Mills TAE, Wheatley L. The role of allergy and atopy in asthma. Curr Opin Pulm Med 1996; 2: 29-34.
37. Platts-Mills TAE, de Weck AL. Dust mite allergens and asthma: a worldwide problem. J Allergy Clin Immunol 1989; 83: 416-27.
38. Sporik R, Holgate ST, Platts-Mills TAE, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. N Engl J Med 1990; 323: 502-7.
39. D'Amato G, Spieksma M, Liccardi G, Jäger S, Russo M, Kontou-Fili K, et al. Pollen-related allergy in Europe. Allergy 1998; 53: 567-78.
40. Sallusto F, Corinti S, Pini C, Biocca MM, Bruno G, Di Felice G. Parietaria judaica-specific T-cell clones from atopic patients: heterogeneity in restriction, Vβ usage, and cytokine profile. J Allergy Clin Immunol 1996; 97(2): 627-37.
41. Polosa R, Li Gotti F, Mangano G, Mastruzzo C, Pistorio MP, Crimi N. Monitoring of seasonal variability in bronchial hyper-responsiveness and sputum cell counts in non-asthmatic subjects with rhinitis and effect of specific immunotherapy. Clin Exp Allergy 2003; 33(7): 873-81.
42. Johnstone DE, Dutton DA. The value of hyposensitisation therapy for bronchial asthma in children: a 14-year study. Pediatrics 1968; 42: 793-802.
43. Peat JK, Mihrshahi S, Kemp AS, Marks GB, Tovey ER, Webb K, Mellis CM, Leeder SR. Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study. J Allergy Clin Immunol. 2004 Oct;114(4):807-13.
44. Watson WT, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993;91:97-101.
45. Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996;98:274-82.